Diamantidis, M.D.; Ikonomou, G.; Argyrakouli, I.; Pantelidou, D.; Delicou, S., on behalf of the International Hemoglobinopathy Research Network (INHERENT).
Genetic Modifiers of Hemoglobin Expression from a Clinical Perspective in Hemoglobinopathy Patients with Beta Thalassemia and Sickle Cell Disease. Int. J. Mol. Sci. 2024, 25, 11886.
https://doi.org/10.3390/ijms252211886
AMA Style
Diamantidis MD, Ikonomou G, Argyrakouli I, Pantelidou D, Delicou S on behalf of the International Hemoglobinopathy Research Network (INHERENT).
Genetic Modifiers of Hemoglobin Expression from a Clinical Perspective in Hemoglobinopathy Patients with Beta Thalassemia and Sickle Cell Disease. International Journal of Molecular Sciences. 2024; 25(22):11886.
https://doi.org/10.3390/ijms252211886
Chicago/Turabian Style
Diamantidis, Michael D., Georgia Ikonomou, Ioanna Argyrakouli, Despoina Pantelidou, and Sophia Delicou on behalf of the International Hemoglobinopathy Research Network (INHERENT).
2024. "Genetic Modifiers of Hemoglobin Expression from a Clinical Perspective in Hemoglobinopathy Patients with Beta Thalassemia and Sickle Cell Disease" International Journal of Molecular Sciences 25, no. 22: 11886.
https://doi.org/10.3390/ijms252211886
APA Style
Diamantidis, M. D., Ikonomou, G., Argyrakouli, I., Pantelidou, D., & Delicou, S., on behalf of the International Hemoglobinopathy Research Network (INHERENT).
(2024). Genetic Modifiers of Hemoglobin Expression from a Clinical Perspective in Hemoglobinopathy Patients with Beta Thalassemia and Sickle Cell Disease. International Journal of Molecular Sciences, 25(22), 11886.
https://doi.org/10.3390/ijms252211886
